Under the project name KLS ONE, Karl and Christian Leibinger have set the goal of integrating the business operations of the five German companies of the KLS Martin Group - Karl Leibinger Medizintechnik GmbH & Co. KG (KLM), Mondeal Medical Systems GmbH, Rudolf Buck GmbH, Gebrüder Martin GmbH & Co. KG and KLS Martin GmbH & Co. KG - to become one company in the mid-term. This is primarily a simplification of the corporate structure.

The Mühlheim-based company Karl Leibinger Medizintechnik initially plans to integrate Rudolf Buck GmbH and the medical technology company Mondeal Medical Systems GmbH, also located in Mühlheim, into the business operations of Karl Leibinger Medizintechnik.

The Karl Leibinger Group was founded in 1896 by Ludwig Leibinger in Mühlheim as a factory for surgical instruments and is now managed by the fourth and fifth generations of Karl and Christian Leibinger. The group of companies has been owned by the Leibinger family since its founding, employs approximately 1,700 people worldwide and generated sales of approximately 300 million euros in 2020.

Implant systems for oral and maxillofacial surgery, neurosurgery, hand and foot surgery, surgical instruments, electrosurgical units and surgical lasers, operating lights and sterilization containers are produced at the sites in Mühlheim, Freiburg, Jacksonville (USA) and Penang (Malaysia). In North and Central America, the products are distributed through a subsidiary, and in the rest of the world through Gebrüder Martin.

Rudolf Buck was the initiator and co-founder of the marketing and sales company Gebrüder Martin in 1923. His own company, founded in 1928, rounds out the KLS Martin Group's overall offering in the field of surgical instruments as well as with specialty products. 

Since 1994, Mondeal Medical Systems GmbH has stood for service, quality, precision, tradition and result orientation. The product range includes solutions for neurosurgery, oral and maxillofacial surgery, orthodontics, as well as hand and foot surgery. In 2019, the Karl Leibinger Group acquired the shares in Mondeal.

The integration of Rudolf Buck GmbH and Mondeal Medical Systems GmbH is expected to take place in spring 2022. The employees of Mondeal and Buck have already been informed. "We are now one step closer to the goal of becoming one company. It is important for us to work out synergies and solutions for meaningful integration in a joint exchange," says Karl Leibinger, President and CEO at KLS Martin Group. 

Christian Leibinger, President and CEO of the KLS Martin Group, explains: "All employees of the mentioned companies will continue to work for the KLS Martin Group." Arno Fritz, CEO and founder of Mondeal: "I am firmly convinced that my life's work Mondeal and all employees are facing a successful future with the transition to the KLS Martin Group. Only with the appropriate structures can a medical technology company nowadays withstand the growing regulatory requirements."

In the course of the merger, there will be employee transfers. It is planned that the majority of Mondeal and Buck employees will transfer to Karl Leibinger Medizintechnik. Individual subdivisions will also move to Gebrüder Martin. Mathias Fritz, Managing Director at Mondeal, and Joachim Klüppel, Managing Director at Buck, are also looking forward to being actively involved in the detailed planning of the integration that is now pending.

Michael Martin, President of the KLS Martin Group, joins in: "We are looking forward to integrating the five sites into one company. By creating cross-site processes, interfaces can be reduced and workflows simplified." 

"We are convinced that this is the right step for the future success of the KLS Martin Group. We are thus strengthening the competitiveness of the KLS Martin Group and making every single job even safer in the long term," Christian Leibinger summarizes. 

The next step is to plan in detail how the business operations of Buck and Mondeal can best be integrated at Karl Leibinger Medizintechnik.

This site uses third party website-tracking-technologies to provide their services. I agree and can revoke or change my consent at any time with future effect.

Settings Accept Imprintprivacy policy